Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-09

Study Completion Date

2026-05-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pharmacists working within a multidisciplinary team have a role to play in detecting the potential iatrogenic origin of a hospital admission, in order to implement measures to improve medication use appropriately and limit readmissions for medication-related iatrogenesis. The iatrogenic detection process depends on the individual involved, their experience, and any tools consulted. Indeed, detection aids have their place in this process and aim for better identification. For example, a questionnaire called AT HARM 10 was developed by a team of experienced pharmacists to identify hospitalizations related to medication-related iatrogenesis. The use of this tool has been validated for pharmacists as well as for pharmacy students: interns and fifth-year medical students.

Identifying iatrogenic drug events among patients presenting to the emergency department using the AT HARM 10 grid in order to intervene and adapt therapeutic management. This clinical pharmacy activity complements what is already included in routine care (medication review, pharmaceutical analysis, and pharmaceutical intervention to adapt treatment).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adverse Drug Events at Emergency Department

NCT03442010

Adverse Drug Event

COMPLETED

Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse

NCT07023419

Psychiatric Disorders

RECRUITING

Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department

NCT04173546

Psychiatric Emergency Drug Use

COMPLETED

Divided Drug Delivery

NCT02869724

Hospitalized for Voluntary Drug Intoxication

UNKNOWN NA

Psychoactive Drug Uses Among Medical and Pharmacy Students

NCT05115981

Psychoactive Substance Use Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iatrogenic Drug Events

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (\> 65 years old)
* Treated in the emergency department of Hautepierre Hospital
* Presenting a prioritization score \> 7 according to the Von Korff score
* Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes.

Exclusion Criteria

\- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes

Minimum Eligible Age

66 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No